Prognostic Significance of the European LeukemiaNet Standardized System for Reporting Cytogenetic and Molecular Alterations in Adults With Acute Myeloid Leukemia
Krzysztof Mrózek(The Ohio State University), Clara D. Bloomfield(North Shore University Hospital), Heiko Becker(University of Freiburg), Klaus H. Metzeler(University Hospital Leipzig), Maria R. Baer(University of Maryland, Baltimore), Jessica Kohlschmidt(The Ohio State University), Guido Marcucci(City of Hope), Jonathan E. Kolitz(Memorial Sloan Kettering Cancer Center), Richard M. Stone(Dana-Farber Cancer Institute), Richard A. Larson(Urbana University), Andrew J. Carroll(University of Alabama at Birmingham), Joseph O. Moore(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Deedra Nicolet(The Ohio State University), Susan P. Whitman(The Ohio State University Wexner Medical Center), Nyla A. Heerema(The Ohio State University), Yue-Zhong Wu(University of Iowa), Mark J. Pettenati, Shivanand R. Patil(University of Iowa Hospitals and Clinics), Sebastian Schwind, AnneMarie W. Block(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Kati Maharry(Peter MacCallum Cancer Centre)
Cited by 408
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k